Skip to main
STXS

Stereotaxis Inc (STXS) Stock Forecast & Price Target

Stereotaxis Inc (STXS) Analyst Ratings

Based on 2 analyst ratings
Buy
Strong Buy 50%
Buy 50%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Stereotaxis is expected to see significant growth and leverage in their business as regulatory and commercial milestones are achieved, with the potential for cash flow positivity in the next few years. The company has a strong focus on expanding its presence in robotics and automation with recurring revenue, and their recent collaboration with CardioFocus on a robotic Pulsed Field Ablation system adds to their innovative portfolio. Additionally, the company has a solid financial standing, with increasing revenue growth and a healthy cash position.

Bears say

Stereotaxis is focusing on expanding its product portfolio while waiting for key products to receive FDA clearance, which poses significant delays and risks. The company faces competitive and reimbursement risks, as well as potential challenges with regulatory approvals and supply chain management. Furthermore, the company's recent collaboration with CardioFocus may not bring immediate revenue growth and success, and may face challenges in clinical trials and regulatory reviews.

Stereotaxis Inc (STXS) has been analyzed by 2 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 50% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Stereotaxis Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Stereotaxis Inc (STXS) Forecast

Analysts have given Stereotaxis Inc (STXS) a Buy based on their latest research and market trends.

According to 2 analysts, Stereotaxis Inc (STXS) has a Buy consensus rating as of May 1, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $4, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $4, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Stereotaxis Inc (STXS)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.